Skip to main content
. 2022 Feb 3;9:800915. doi: 10.3389/fped.2021.800915

Table 2.

Pathogenic alterations in CDH patients of which the defect size was registered.

Defect size (n) Syndrome (n) n Death Chromosome Type Inheritance Zygosity Genetic change
A (n = 10) Wolf Hirschshorn Syndrome 1 NR 4p156.3 Loss de novo het 46, XY FISH: ish del (4) (p16.3p16.3) (D4S96-)
Louys-Dietz syndrome V 1 NR 14q24 Frameshift AD het NM_003239.4 (TGFB3): c.232del.G, p. (Glu78fs)
Marfan syndrome 1 NR 15q21.1 Frameshift AD het NM_000138.5 (FBN1):c1301_1302del, p. (Tyr434Serfs*17)
Microdeletion 1 NR 16p13.3 Loss de novo het 46, XY arr[hg18] 16p13.3 (154,014–174,381) x1
Arterial tortuosity syndrome 1 NR 20q13 Missense AR hom NM_030777.4 (SLC2A10): c.127 6G>T, p. (Gly426Trp)
Down syndrome 4 D (1), NR (3) 21 Aneuploidy de novo het 47, XX / 47, XY + 21
Down syndrome 1 NR 21 Aneuploidy ut het 46, XY, t (15;21) (p12; p12)
B (n = 4) Microduplication 1 NR 4p15.2p14 Gain de novo het arr [hg18] 4p15.2p14 (224,500,018–38,700,366) x3
Sotos syndrome 1 NR 5q35.2 Missense de novo het NM_022455.5 (NSD1): c.5685C>G, p. (Cys1895Tyrp)
Microduplication 1 NR 7q31.33–36.3 Gain de novo het arr[hg19]7q31.33q36.3 (125839750_159124173) x3[0.2]/arr[hg19]7q31.33q36.3 (125839750_159124173) x4[0.1]
Microdeletion 1 D 8p23.1 Loss de novo het arr[hg18] 8p23.1 (8,139,051–12,619,015) x1
C (n = 5) Fraser syndrome 1 NR 9p22.3 Splicing de novo het NM_144966.7 (FREM1): c.5334 + 1G > A (r.spl?)
Microdeletion 9p22.3 Loss Inherited het arr[hg18] 9p22.3 (14,871,409–14,938,830) x1
Prader Willi 1 NR 15q11 Gain de novo het arr[hg18]15q11.2q13.1 (20,319,702–26,143,385) x3
Microdeletion 1 NR 17q12 Loss de novo het arr[hg19] 17q12 (34815551_36249430) x1
Congenital disorder of glycosylation 1 NR Xp11.23 Loss de novo het NM_001042498 (SLC35A2): c.753delG, p.(Trp251fs)
XY reversal 1 D XY ? de novo ? –*
D (n = 2) Microdeletion 1 N 15q26 Loss de novo het arr[hg18] chr15:80,689,404–82,938,351 x 1 and
17p12 het arr[hg18] chr17:14049619–15497020 x1
Microdeletion 1 D 22q11.2 Gain ut het 47, XY, +der (22) t (11;22) (q23.3; q11.2) mat

Genetic tests included karyotyping, SNP array or Whole exome sequencing. AR, Autosomal recessive; XLR, X-linked recessive; CH, compound heterozygote; n, number of patients; ut, unbalanced translocation.